Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Immune activities and specific genes are important in male pattern baldness.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Misdiagnosis led to unnecessary treatment due to a genetic mutation affecting thyroid hormone resistance.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

A new treatment for hair loss shows promise with fewer side effects.

Total glucosides of paeony may help treat alopecia areata by reducing inflammation and hair loss.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Gambogic Amide may prevent hair greying and promote hair growth by maintaining hair pigmentation.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Licorice component glycyrrhizic acid may reduce skin side effects from cancer treatment.

Platelet-rich plasma (PRP) helps regrow hair in male pattern baldness.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Certain gene variations may increase the risk of hair loss in Egyptians.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Gagamchengyoung-tang may help improve hair growth and scalp health in certain alopecia patients.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

Thorough evaluations and conservative management can lead to positive outcomes in pediatric adrenocortical carcinoma.